VBLT - Vascular Biogenics prices $25M stock offering

Vascular Biogenics (VBLT) prices public offering of 5.15M shares, to certain investors in lieu thereof pre-funded warrants to purchase 8.05M shares, at $1.90 per share and $1.89 per pre-funded warrant.Underwriters' overallotment option is to purchase up to additional 15% of offering.Gross proceed expected to be $25M.The company says it intends to use the net proceeds for working capital and other general corporate purposes.Offering will close on April 13, 2021.Stock down 3.14% premarket.Previously (March 25): VBL Therapeutics EPS misses by $0.02, misses on revenue

For further details see:

Vascular Biogenics prices $25M stock offering